David J. Blanchard

Array ( [id] => 314529 [patent_doc_number] => 07524498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Human immunomodulatory monoclonal antibodies for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/854160 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 33 [patent_no_of_words] => 32227 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524498.pdf [firstpage_image] =>[orig_patent_app_number] => 11854160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4932908 [patent_doc_number] => 20080003683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'CE7-SPECIFIC REDIRECTED IMMUNE CELLS' [patent_app_type] => utility [patent_app_number] => 11/849643 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15751 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003683.pdf [firstpage_image] =>[orig_patent_app_number] => 11849643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704075 [patent_doc_number] => 20080063598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Humanized Antibody' [patent_app_type] => utility [patent_app_number] => 11/841358 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21390 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20080063598.pdf [firstpage_image] =>[orig_patent_app_number] => 11841358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5289986 [patent_doc_number] => 20090022716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'COMBINATION METHODS OF INHIBITING TUMOR GROWTH WITH A VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 11/828285 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 31366 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022716.pdf [firstpage_image] =>[orig_patent_app_number] => 11828285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 24363 [patent_doc_number] => 07795413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors' [patent_app_type] => utility [patent_app_number] => 11/767326 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 35593 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795413.pdf [firstpage_image] =>[orig_patent_app_number] => 11767326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657116 [patent_doc_number] => 20080025977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD59' [patent_app_type] => utility [patent_app_number] => 11/807681 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 26504 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025977.pdf [firstpage_image] =>[orig_patent_app_number] => 11807681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126393 [patent_doc_number] => 20070238664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => '70 Human Secreted Proteins' [patent_app_type] => utility [patent_app_number] => 11/751886 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73780 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238664.pdf [firstpage_image] =>[orig_patent_app_number] => 11751886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322731 [patent_doc_number] => 07517964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'RS7 antibodies' [patent_app_type] => utility [patent_app_number] => 11/745896 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 24805 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517964.pdf [firstpage_image] =>[orig_patent_app_number] => 11745896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230304 [patent_doc_number] => 20070292411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Antibodies That Immunospecifically Bind to TRAIL Receptors' [patent_app_type] => utility [patent_app_number] => 11/745734 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 192897 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292411.pdf [firstpage_image] =>[orig_patent_app_number] => 11745734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669772 [patent_doc_number] => 20080044832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'METHOD OF DETERMINING THE PROGNOSIS OF HUMAN CANCER' [patent_app_type] => utility [patent_app_number] => 11/737573 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5335 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044832.pdf [firstpage_image] =>[orig_patent_app_number] => 11737573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 73244 [patent_doc_number] => 07749504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Anti-TAT188 antibodies' [patent_app_type] => utility [patent_app_number] => 11/733861 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 249 [patent_figures_cnt] => 175 [patent_no_of_words] => 82255 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749504.pdf [firstpage_image] =>[orig_patent_app_number] => 11733861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44464 [patent_doc_number] => 07777017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria' [patent_app_type] => utility [patent_app_number] => 11/724040 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 21362 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777017.pdf [firstpage_image] =>[orig_patent_app_number] => 11724040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6485774 [patent_doc_number] => 20100093008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'PHOSPHO-SPECIFIC ANTIBODIES TO FLT3 (TYR969) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/681521 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8183 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093008.pdf [firstpage_image] =>[orig_patent_app_number] => 11681521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5252798 [patent_doc_number] => 20070134254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'EphA2 agonistic monoclonal antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/650287 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 37622 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134254.pdf [firstpage_image] =>[orig_patent_app_number] => 11650287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219292 [patent_doc_number] => 20070160603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Antibodies Against Tumor Necrosis Factor Delta (APRIL)' [patent_app_type] => utility [patent_app_number] => 11/614212 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 65804 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160603.pdf [firstpage_image] =>[orig_patent_app_number] => 11614212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100789 [patent_doc_number] => 20070184051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Anti CD44 antibodies for eradicating stem cells' [patent_app_type] => utility [patent_app_number] => 11/604784 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2921 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184051.pdf [firstpage_image] =>[orig_patent_app_number] => 11604784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056383 [patent_doc_number] => 20070059305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Neutralizing human anti-IGFR antibody' [patent_app_type] => utility [patent_app_number] => 11/598618 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26904 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059305.pdf [firstpage_image] =>[orig_patent_app_number] => 11598618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119889 [patent_doc_number] => 20070141603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Mammalian TNF-alpha convertases' [patent_app_type] => utility [patent_app_number] => 11/598469 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13737 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141603.pdf [firstpage_image] =>[orig_patent_app_number] => 11598469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219778 [patent_doc_number] => 20070161089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Method of Producing Pan-Specific Antibodies' [patent_app_type] => utility [patent_app_number] => 11/556917 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19122 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161089.pdf [firstpage_image] =>[orig_patent_app_number] => 11556917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149675 [patent_doc_number] => 20070049735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'ANTIBODIES THAT BIND BOTH BCMA AND TACI' [patent_app_type] => utility [patent_app_number] => 11/553643 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22780 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049735.pdf [firstpage_image] =>[orig_patent_app_number] => 11553643 [rel_patent_id] =>[rel_patent_doc_number] =>)